Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia-Reference-Cited by-同舟云学术

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

Published:2003-02-24 Issue:5 Volume:100 Page:2742-2747
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Marijt W. A. E.,Heemskerk M. H. M.,Kloosterboer F. M.,Goulmy E.,Kester M. G. D.,van der Hoorn M. A. W. G.,van Luxemburg-Heys S. A. P.,Hoogeboom M.,Mutis T.,Drijfhout J. W.,van Rood J. J.,Willemze R.,Falkenburg J. H. F.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference45 articles.

1. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

2. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

3. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

4. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

Cited by 369 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCR targeting hematopoiesis to cure leukemia;Blood;2024-09-05

2. Production of donor-derived cytotoxic T lymphocytes with potent anti-leukemia activity for adoptive immunotherapy in high-risk pediatric patients given haploidentical hematopoietic stem cell transplantation;Cytotherapy;2024-08

3. Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens;Blood;2024-05-02

4. Minor histocompatibility antigens represented in HLA-A*02:01 and their search strategies;Oncohematology;2023-09-13

5. Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia;Best Practice & Research Clinical Haematology;2023-06